This podcast features a panel discussion from the 2026 Chief Medical Officer Summit 360°, with biotech CMOs and representatives from pharma companies. Together, they address how interactions around partnerships or acquisitions differ from those of investment from biotech companies and how CMOs can support those conversations. This includes:
- How pharma companies analyze potential partners
- What biotech companies can do to best partner with pharma
- How the CMO fits into various phases of transactions
- Appreciating how different c-suite colleagues and direct reports experience these transactions
- The different pharma teams CMOs will interact with
- Common challenges to partnerships and how to pre-empt them
- What happens after the acquisition
To learn more about the Chief Medical Officer Summit 360°, please visit CMOSummit360.com.